VET PFAS Act

Bill Number

H.R. 3639

Origin Chamber

House

Congress

119th Congress, Session 1

Policy Area

Armed Forces and National Security

Status

Introduced

Latest Action

2025-06-06: Referred to the Subcommittee on Health.

Last Updated

2026-06-30T08:05:56Z

AI-Generated Summary

Purpose

The "Veterans Exposed to Toxic PFAS Act" (H.R. 3639), also known as the "VET PFAS Act," aims to provide healthcare access and disability benefits to U.S. military veterans and their dependents who were exposed to per- and polyfluoroalkyl substances (PFAS)—a group of human-made chemicals used in products like firefighting foam and non-stick coatings—at contaminated military installations. It addresses health risks from PFAS exposure, such as through contaminated drinking water, by expanding eligibility for Department of Veterans Affairs (VA) services without requiring proof that the health issues directly resulted from military service.

Key Provisions

• Healthcare for Veterans:
• Veterans who served on active duty (or qualifying reserve duty) at a "covered military installation" (sites with documented PFAS exposure, including via contaminated water wells) become eligible for VA hospital care and medical services starting 90 days after enactment.
• Covered conditions include specific illnesses linked to perfluorooctanoic acid (PFOA, a type of PFAS): high cholesterol, ulcerative colitis, thyroid disease, testicular cancer, kidney cancer, and pregnancy-induced hypertension.
• For other PFAS types, eligibility extends to any disease or illness identified in a 2017 federal study (under the National Defense Authorization Act for Fiscal Year 2018) as positively associated with PFAS exposure, as determined by the VA Secretary in consultation with the Agency for Toxic Substances and Disease Registry (ATSDR).
• Healthcare for Dependents:
• Family members (including those in utero during the mother's residence at a covered site) of eligible veterans qualify for VA care for the same conditions, also starting 90 days after enactment.
• Care is limited to cases where health issues cannot be clearly attributed to non-exposure causes, per VA guidelines; it requires exhausting third-party insurance claims first; and is subject to available funding.
• Presumption of Service Connection:
• For disability compensation under VA rules, the listed PFAS-related conditions in affected veterans are presumed to be caused or worsened by military service at covered sites, eliminating the need for individual proof of causation.
• This applies to active duty and specified reserve service periods.
• Reporting Requirements:
• The VA must submit annual reports to congressional Veterans' Affairs committees for three years following submission of the 2017 PFAS study to Congress.
• Reports will detail usage statistics, including numbers served, denied applications (with reasons), pending cases, and specific conditions treated.

Significant Changes to Existing Law

• Amends Section 1710(e) of Title 38, U.S. Code (governing VA healthcare eligibility) by adding a new subparagraph (J) to expand coverage for PFAS-exposed veterans, overriding requirements for direct medical evidence linking conditions to service.
• Adds a new Section 1787A to Subchapter VIII of Chapter 17, introducing healthcare eligibility for dependents of PFAS-exposed veterans—a novel extension not previously covered under VA family care provisions.
• Inserts a new Section 1116C into Chapter 11 of Title 38, creating a presumption of service connection for PFAS-related illnesses, similar to presumptions for Agent Orange or Gulf War exposures but specifically tailored to PFAS at military sites.
• Treats certain reserve component service as equivalent to active duty for PFAS exposure purposes, broadening eligibility beyond standard definitions.

Potential Impacts

• On Government Agencies: The VA will face increased demand for healthcare and compensation services, potentially straining budgets and requiring new administrative processes for eligibility verification and reporting. Collaboration with ATSDR for condition determinations may enhance inter-agency coordination on environmental health. Annual reports could inform future funding and policy adjustments.
• On Citizens: Eligible veterans and dependents gain easier access to free or low-cost VA treatment and benefits for PFAS-linked conditions, reducing personal financial burdens and improving health outcomes. However, care is capped by appropriations, and denials may occur if other causes are identified.
• On International Relations: Minimal direct impact, as the bill focuses on U.S. military sites and domestic veterans; it could indirectly support U.S. leadership in addressing global PFAS contamination through precedent for environmental accountability in defense operations.

Main Stakeholders Affected

• Veterans and Dependents: Primary beneficiaries, including those stationed at PFAS-contaminated bases (e.g., via historical use of firefighting foams), who may now access care and compensation without lengthy proof processes.
• Department of Veterans Affairs (VA): Responsible for implementing expanded services, determinations, and reporting; includes the Secretary and Under Secretary for Health.
• Agency for Toxic Substances and Disease Registry (ATSDR): Consults with VA on additional PFAS-linked conditions based on existing research.
• Congressional Committees: Veterans' Affairs Committees in the House and Senate, which receive reports and oversee implementation.
• Reserve Component Members: Affected by the reclassification of certain service periods as active duty for eligibility.

Notable Legal, Constitutional, or Political Implications

• Legal: Establishes a rebuttable presumption (under Section 1113 of Title 38) for service connection, streamlining claims but allowing VA to deny if evidence shows non-service causes; this could lead to more efficient processing but potential litigation over site designations or condition links. Relies on the 2017 NDAA study for scientific basis, ensuring evidence-based expansion without new research mandates.
• Constitutional: Aligns with Congress's authority under Article I, Section 8 to provide for military welfare and spend on veterans' benefits; no apparent conflicts with due process or equal protection, as eligibility is tied to service and exposure.
• Political: Bipartisan sponsorship (introduced May 29, 2025, by Rep. Lawler and cosponsors from both parties) signals broad support for veteran environmental health issues; may pressure defense and environmental agencies for broader PFAS cleanup at military sites, influencing future appropriations debates and toxic exposure legislation.

This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.

Sponsor

Rep. Lawler, Michael [R-NY-17]

Cosponsors (26)

Rep. Riley, Josh [D-NY-19], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Tlaib, Rashida [D-MI-12], Rep. Magaziner, Seth [D-RI-2], Rep. DelBene, Suzan K. [D-WA-1], Rep. Khanna, Ro [D-CA-17], Rep. Chu, Judy [D-CA-28], Rep. Carson, André [D-IN-7], Rep. Pettersen, Brittany [D-CO-7], Rep. Dean, Madeleine [D-PA-4], Rep. Craig, Angie [D-MN-2], Rep. Goodlander, Maggie [D-NH-2], Rep. Kennedy, Timothy M. [D-NY-26], Rep. Harder, Josh [D-CA-9], Rep. Vindman, Eugene Simon [D-VA-7], Rep. McClain Delaney, April [D-MD-6], Rep. Cohen, Steve [D-TN-9], Rep. Gottheimer, Josh [D-NJ-5], Rep. Sorensen, Eric [D-IL-17], Rep. Min, Dave [D-CA-47], Rep. Gillen, Laura [D-NY-4], Rep. Levin, Mike [D-CA-49], Rep. Lofgren, Zoe [D-CA-18], Rep. Grijalva, Adelita S. [D-AZ-7], Rep. Stevens, Haley M. [D-MI-11], Rep. Dingell, Debbie [D-MI-6]

Recent Actions

• 2025-06-06: Referred to the Subcommittee on Health.
• 2025-05-29: Referred to the House Committee on Veterans' Affairs.
• 2025-05-29: Introduced in House
• 2025-05-29: Introduced in House

Bill Versions

• Veterans Exposed to Toxic PFAS Act — issued 2025-05-29 — PDF (10 pages)